Augmedics, a pioneer in augmented reality (AR) surgical navigation, announced it has been named the successful bidder for the digital health assets of Surgalign and Holo Surgical following a competitive auction process. The news comes a month following Augmedics’ $82.5 million raise to accelerate the adoption of augmented reality spine surgery and further strengthens the company’s AR and AI portfolio with intellectual property and other digital health assets.
Latest Cioinfluence Interview: CIO Influence Interview with Joe Ramieri, VP of North America at Instabase
“We are pleased to further expand our strong technical and intellectual property position in the field of augmented reality surgery with this planned acquisition”
“We are pleased to further expand our strong technical and intellectual property position in the field of augmented reality surgery with this planned acquisition,” said Augmedics President & CEO Kevin Hykes. “Augmedics shares Surgalign’s passion for developing cutting-edge technology in the name of improved surgical outcomes. We look forward to leveraging these assets to further evolve the xvision platform.”
Read More About Cioinfluence Interview: CIO Influence Interview with Michael Berthold, CEO at KNIME
The sale will close pending approval by the Bankruptcy Court at a hearing set for August 8, 2023.
Augmedics pioneers cutting-edge augmented reality technologies to improve surgical outcomes. The company’s revolutionary xvision Spine System® allows surgeons to see patients’ anatomy as if they have “x-ray vision” and accurately navigate instruments and implants during spine procedures. The first-of-its-kind, FDA-cleared xvision has been used to treat over 4,000 patients and implant more than 20,000 pedicle screws across 21 US states. xvision has consistently demonstrated 97-100% accuracy of pedicle screw placement across multiple patient studies.
Browse The Complete Interview About Cioinfluence: CIO Influence Interview with Filip Verloy, Field CTO for the EMEA Region at Noname Security
[To share your insights with us, please write to sghosh@martechseries.com]
